Women with recurrent ovarian cancer showed clinical benefit when treated with a drug called decitabine before undergoing chemotherapy and a cancer vaccine. This is according to a new study published in the journal Cancer Immunology Research.The research team, led by Dr. via Featured Health News from Medical News Today Read More Here..
Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2014/01/ovarian-cancer-combination-therapy.html
No comments:
Post a Comment